Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 18, 2008
Neurohumoral changes in chronic heart failureLenka Spinarova, Jiri Vitovec
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 13, 2013
Anti-hypertensive strategies in patients with MEtabolic parameters, DIabetes mellitus and/or NephropAthy (the M E D I N A study)Jindrich Spinar, Jiri Vitovec, Miroslav Soucek
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 7, 2010
Usefulness of left ventricle dyssynchrony assessment before cardiac resynchronization implantationJolana Lipoldova, Eva Ozabalova, Jaroslav Meluzin, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 28, 2012
Apolipoprotein E polymorphism is associated with both number of diseased vessels and extent of coronary artery disease in Czech patients with CADJan Machal, Anna Vasku, Ota Hlinomaz, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 7, 2010
Does the resynchronization therapy lead to reduction of symptoms and to improvement of left ventricular functions in patients with chronic heart failure?Eva Ozabalova, Miroslav Novak, Jan Krejci, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 7, 2012
The variable clinical course of peripartum cardiomyopathyJan Krejci, Petr Hude, Lenka Spinarova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 18, 2014
Comparison of clinical outcomes and safety of catheter ablation for atrial fibrillation supported by data from CT scan or three-dimensional rotational angiogram of left atrium and pulmonary veinsFrantisek Lehar, Zdenek Starek, Jiri Jez, et al.
American Heart Journal|January 22, 2005
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HFPrakash C Deedwania, Thomas D Giles, Michael Klibaner, et al.
Pageof 3